Biocon has witnessed encouraging results in the use of its novel biologic Itolizumab for treating some Covid-19 related conditions, the pharmaceutical company said on Friday. Biocon said the first set of trials using the drug were done in Mumbai and Delhi.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3cEbO57
via IFTTT
0 comments:
Post a Comment